(Q43838770)

27 November 2017

0 references

Oral fingolimod in multiple sclerosis: therapeutic modulation of the sphingosine-1-phosphate system (English)

1 reference

reason for deprecated rank

27 November 2017

Orales Fingolimod bei Multipler Sklerose (German)

marking inconsistent with the registered/official identifier/name

1 reference

https://api.crossref.org/works/10.1007/S00115-010-3075-8

13 July 2024

author name string

H-P Hartung

6

1 reference

27 November 2017

O. Aktas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20842337

13 July 2024

J. Ingwersen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20842337

13 July 2024

B. Kieseier

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20842337

13 July 2024

P. Küry

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20842337

13 July 2024

R. Hohlfeld

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20842337

13 July 2024

language of work or name

German

0 references

publication date

1 February 2011

1 reference

full work available at URL

27 November 2017

http://link.springer.com/content/pdf/10.1007/s00115-010-3075-8.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S00115-010-3075-8

http://link.springer.com/article/10.1007/s00115-010-3075-8/fulltext.html

13 July 2024

1 reference

https://api.crossref.org/works/10.1007/S00115-010-3075-8

http://link.springer.com/content/pdf/10.1007/s00115-010-3075-8

13 July 2024

1 reference

https://api.crossref.org/works/10.1007/S00115-010-3075-8

13 July 2024

1 reference

27 November 2017

volume

82

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

215-225

1 reference

https://scigraph.springernature.com/pub.10.1007/s00115-010-3075-8

27 November 2017

exact match

0 references

cites work

Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL.

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Neuronal damage in brain inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

The immune modulator FTY720 targets sphingosine 1-phosphate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Lysophospholipid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Emerging medicinal roles for lysophospholipid signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Bleak prospects for primary progressive multiple sclerosis therapy: downs and downs, but a glimmer of hope

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Cladribin. Development of an oral formulation for the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

FTY720 (fingolimod) for relapsing multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Oral fingolimod (FTY720) for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Essential roles of sphingosine 1-phosphate/S1P1 receptor axis in the migration of neural stem cells toward a site of spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Fingolimod (FTY720) in severe hepatic impairment: pharmacokinetics and relationship to markers of liver function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

p57kip2 is dynamically regulated in experimental autoimmune encephalomyelitis and interferes with oligodendroglial maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Origin of oligodendrocytes in the subventricular zone of the adult brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Cyclical and dose-dependent responses of adult human mature oligodendrocytes to fingolimod.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

FTY720 modulates human oligodendrocyte progenitor process extension and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Central nervous system-directed effects of FTY720 (fingolimod).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Essential role for sphingosine kinases in neural and vascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Sphingosine-1-phosphate induces apoptosis of cultured hippocampal neurons that requires protein phosphatases and activator protein-1 complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Antiproliferative properties of sphingosine-1-phosphate in human hepatic myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Sirt1 contributes critically to the redox-dependent fate of neural progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

S1P inhibits gap junctions in astrocytes: involvement of G and Rho GTPase/ROCK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Finding a way out: lymphocyte egress from lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Molecular dissection of reactive astrogliosis and glial scar formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Sphingosine-1-phosphate: an enigmatic signalling lipid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Active induction of experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

"Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Differential transactivation of sphingosine-1-phosphate receptors modulates NGF-induced neurite extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00115-010-3075-8

First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients

21 January 2018

1 reference

12 December 2020

New cases of progressive multifocal leukoencephalopathy after treatment with natalizumab

1 reference

12 December 2020

Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: action through a specific cell surface receptor

1 reference

12 December 2020

EAE: pitfalls outweigh virtues of screening potential treatments for multiple sclerosis

1 reference

12 December 2020

Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite

1 reference

12 December 2020

FTY720: placebo-controlled study of the effect on cardiac rate and rhythm in healthy subjects

1 reference

12 December 2020

Oral therapies for multiple sclerosis: are we there yet?

1 reference

12 December 2020

Sphingosine-1-phosphate induces proliferation and morphological changes of neural progenitor cells

1 reference

12 December 2020

Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation

1 reference

12 December 2020

FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis

1 reference

12 December 2020

FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine produ

1 reference

12 December 2020

FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration.

1 reference

12 December 2020

Sphingosine-1-phosphate induces proliferation of astrocytes: regulation by intracellular signalling cascades

53

1 reference

https://api.crossref.org/works/10.1007/S00115-010-3075-8

13 July 2024

Identifiers

1 reference

27 November 2017

1 reference